The UK start-up NanoSyrinx Ltd has appointed Jane Dancer to its board as a non-executive director as the company launches its platform for delivering therapeutic proteins to the cytosol. Dr Dancer was previously chief business officer at F-star Biotechnology Ltd and before that, head of business development at Cellzome GmbH.
Dr Dancer holds an MA and PhD in natural sciences from the University of Cambridge and an MBA from the Cambridge Judge Business School.
NanoSyrinx announced the appointment on 10 December 2020.
Copyright 2020 Evernow Publishing Ltd